Increased expression of S1OO calcium binding protein A8 in GM-CSF-stimulated neutrophils leads to the increased expressions of IL-8 and IL-16

Clinical and Experimental Rheumatology

Volumn 29, Issue 5, 2011, Pages 768-775

  Katano, M ^a,b,c,d   Okamoto, K ^a   Suematsu, N ^a   Kurokawa, M S ^a   Nakamura, H ^e   Masuko, K ^a,f   Yudoh, K ^d   Kato, T ^a  

^a ST MARIANNA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

^c Molecuence Corporation   (Japan)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NIPPON MEDICAL SCHOOL   (Japan)

^f SAGAMI WOMEN'S UNIVERSITY   (Japan)

Author keywords

Cytokine; GM CSF; Neutrophil; Rheumatoid arthritis; S100A8

Indexed keywords

CALGRANULIN A; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 16; INTERLEUKIN 8; MESSENGER RNA; IL8 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ADULT; AGED; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOASSAY; MALE; NEUTROPHIL; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; UPREGULATION; WESTERN BLOTTING; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNOVIAL FLUID;

AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CALGRANULIN A; CELLS, CULTURED; DRUG SYNERGISM; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-16; INTERLEUKIN-8; MALE; MIDDLE AGED; NEUTROPHILS; RECOMBINANT PROTEINS; RNA, MESSENGER; SYNOVIAL FLUID;

EID: 83455253434     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. PILLINGER MH. ABRAMSON SB: The neutrophil in rheumatoid arthritis. Rheum Dis Clin North Am 1995; 21: 691-714.
2. EDWARDS SW, HALLETT MB: Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol Today 1997; 18: 320-4. (Pubitemid 27314467)
3. STANCZYK J, KOWALSKI ML, GRZEGORCZYK J et al.: RANTES and Chemotactic Activity in Synovial Fluids From Patients With Rheumatoid Arthritis and Osteoarthritis. Mediators Inflamm 2005; 6: 343-8. (Pubitemid 41803403)
4. GAVIOLI R, RISSO A, SMILOVICH D et al:. CD69 molecule in human neutrophils: its expression and role in signal-transducing mechanisms. Cell Immunol 1992; 142: 186-96.
5. SHIMADA S, NAKAMURA M, TANAKA Y et al:. Crosslinking of the CD69 molecule enhances S100A9 production in activated neutrophils. Microbiol Immunol 2007; 51: 87-98. (Pubitemid 46155190)
6. ATZENI F, DEL PAPA N, SARZI-PUTTINI P, BERTOLAZZI F, MINONZIO F, CAPSONI F: CD69 expression on neutrophils from patients with rheumatoid arthritis. Clin Exp Rheumatol 2004; 22: 331-4. (Pubitemid 38585236)
7. SCAPINI P, LAPINETVERA JA, GASPERINI S, CALZETTI F, BAZZONI F, CASSATELLA MA: The neutrophil as a cellular source of chemokines. Immunol Rev 2000; 177: 195-203.
8. COOK N, DEXTER TM, LORD BI, CRAGOE EJJ, WHETTON AD: Identification of a common signal associated with cellular proliferation stimulated by four haemopoietic growth factors in a highly enriched population of granulocyte/macrophage colony-forming cells. EMBO J 1989; 8: 2967-74. (Pubitemid 19274998)
9. METCALF D: The induction and inhibition of differentiation in normal and leukaemic cells. Phil Trans R Soc Lond 1990; 327: 99-109.
10. WHETTON AD, DEXTER TM: Myeloid haemopoietic growth factors. Biochim Biophys Acta 1989; 989: 111-32. (Pubitemid 20008967)
11. LIESCHKE GJ, GRAIL D. HODGSON G et al:. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 1994; 84: 1737-46. (Pubitemid 24286121)
12. METCALF D, BEGLEY CG, WILLIAMSON DJ et al:. Hemopoietic responses in mice injected with purified recombinant murine GMCSF. Exp Hematol 1987; 15: 1-9. (Pubitemid 17029119)
13. ATZENI F, SCHENA M, ONGARI AM et al:. Induction of CD69 activation molecule on human neutrophils by GM-CSF, IFN-gamma, and IFN-alpha. Cell Immunol 2002; 220: 20-9. (Pubitemid 36444496)
14. AGRO A, JORDANA M, CHAN KH et al:. Synoviocyte derived granulocyte macrophage colony stimulating factor mediates the survival of human lymphocytes. J Rheumatol 1992; 19: 1065-9.
15. HAMILTON JA, PICCOLI DS, CEBON J, LAYTON JE: Cytokine regulation of colony-stimulating factor (CSF) production in cultured human synovial fibroblasts. II. Similarities and differences in the control of interleukin-1 induction of granulocyte-macrophage CSF and granulocyte-CSF production. Blood 1992; 79: 1413-9.
16. BELL AL, MAGILL MK, MCKANE WR, KIRK F, IRVINE AE: Measurement of colony-stimulating factors in synovial fluid: potential clinical value. Rheumatol Int 1995; 14: 177-82.
17. CAMPBELL IK, BENDELE A, SMITH DA, HAMILTON JA: Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice. Ann Rheum Dis 1997; 56: 364-8. (Pubitemid 27305424)
18. COOK AD, BRAINE EL, CAMPBELL IK, RICH MJ, HAMILTON JA: Blockade of collageninduced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res 2001;3:293-8. (Pubitemid 32821522)
19. SEKIGAWA I, YANAGIDA M, IWABUCHI K et al:. Protein biomarker analysis by mass spectrometry in patients with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha antibody therapy. Clin Exp Rheumatol 2008; 26: 261-7. (Pubitemid 351659132)
20. LI T, HUANG Z, ZHENG B, LIAO Z, ZHAO L, GU J: Serum disease-associated proteins of ankylosing spondylitis: results of a preliminary study by comparative proteomics. Clin Exp Rheumatol 2010; 28: 201-7.
21. KATANO M, OKAMOTO K, ARITO M et al:. Implication of granulocyte- macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis. Arthritis Res Ther 2009; 11: R3.
22. GUIGNARD F, MAUEL J, MARKERT M: Identification and characterization of a novel human neutrophil protein related to the S1OO family. Biochem J 1995; 309: 395-401.
23. SCHAFER BW, HEIZMANN CW: The S1OO family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 1996; 21: 134-40.
24. NEWTON RA, HOGG N: The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 1998; 160: 1427-35. (Pubitemid 28093444)
25. HASHEMI FB, MOLLENHAUER J, MADSEN LD et al:. Myeloid-related protein (MRP)-8 from cervico-vaginal secretions activates HIV replication. AIDS 2001; 15:441-9. (Pubitemid 32207563)
26. NISHIMURA F, TERRANOVA VP, SAWA T, MURAYAMA Y: Migrationinhibitory factor related protein-8 (MRP-8) is an autocrine chemotactic factor forperiodontal ligament cells. J Dent Res 1999; 78: 1251-5. (Pubitemid 32501264)
27. ALTMAN R, ASCH E, BLOCH D et al:. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986; 29: 1039-49.
28. ARNETT FC, EDWORTHY SM, BLOCH DA et al:. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
29. SEGAL AW, JONES OT: Rapid incorporation of the human neutrophil plasma membrane cytochrome b into phagocytic vacuoles. Biochem Biophys Res Commun 1980; 92: 710-5. (Pubitemid 10098614)
30. SUNAHORI K, YAMAMURA M, YAMANA J et al:. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res Ther 2006; 8: R69.
31. EUE I, PIETZ B, STORCK J, KLEMPT M, SORG C: Transendothelial migration of 27E10+ human monocytes. Int Immunol 2000; 12: 1593-604.
32. RYCKMAN C, VANDAL K, ROULEAU P, TALBOT M.TESSIER PA: Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immuno 2003; 170: 3233-42. (Pubitemid 36302201)
33. FOELL D, ROTH J: Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum 2004; 50: 3762-71. (Pubitemid 39643922)
34. KOCH AE, KUNKEL SL, BURROWS JC et al:. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J Immunol 1991; 147:2187-95.
35. KRAAN MC, PATEL DD, HARINGMAN JJ et al:. The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8). Arthritis Res 2001;3:65-71. (Pubitemid 32223807)
36. DELEURAN B, LEMCHE P, KRISTENSEN M et al:. Localisation of interleukin 8 in the synovial membrane, cartilage-pannus junction and chondrocytes in rheumatoid arthritis. Scand J Rheumatol 1994; 23: 2-7. (Pubitemid 24052889)
37. YOKOTA K, MIYAZAKI T, HIRANO M, AKIYAMA Y, MIMURA T: Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Rheumatol 2006; 33: 463-71. (Pubitemid 43334566)
38. BELPERIO JA, KEANE MP, ARENBERG DA et al:. CXC chemokines in angiogenesis. J LeukocBiol 2000; 68: 1-8.
39. KANEKO S, SATOH T, CHIBA J, JU C, INOUE K, KAGAWA J: Interleukin-6 and interleukin- 8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther 2000; 6: 71-9.
40. LARD LR, ROEP BO, TOES RE, HUIZINGA TW: Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis. J Rheumatol 2004;31:35-9. (Pubitemid 38067519)
41. RUMSAENGV, CRUIKSHANK WW, FOSTER B et al:. Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J Immunol 1997; 159: 2904-10. (Pubitemid 127681313)
42. REICH K, HUGO S, MIDDEL P, BLASCHKE V, HEINE A, NEUMANN C: The maturation-dependent production of interleukin-16 is impaired in monocyte-derived dendritic cells from atopic dermatitis patients but is restored by inflammatory cytokines TNF-alpha and IL-lbeta. Exp Dermatol 2004; 13: 740-7. (Pubitemid 39625220)
43. SCHULER MK, SELL S, AICHER WK: Protein kinase signals activate interleukin 16 encoding transcripts in rheumatoid arthritis versus osteoarthritis synovial fibroblasts. Ann Rheum Dis 2003; 62: 182-3. (Pubitemid 36135398)
44. CENTER DM. KORNFELD H, CRUIKSHANK WW: Interleukin 16 and its function as a CD4 ligand. Immunol Today 1996; 39: 476-81. (Pubitemid 26323317)
45. PARADA NA, CENTER DM, KORNFELD H et al:. Synergistic activation of CD4+ T cells by IL-16 and IL-2. J Immunol 1998; 160:2115-20. (Pubitemid 28119889)
46. HERMANN E, DARCISSAC E, IDZIOREK T, CAPRON A, BAHR GM: Recombinant interleukin-16 selectively modulates surface receptor expression and cytokine release in macrophages and dendritic cells. Immunology 1999;97:241-8. (Pubitemid 29274156)
47. BAIER M, BANNERT N, WERNER A, LANG K, KURTH R: Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc Natl Acad Sci USA 1997; 94: 5273-7. (Pubitemid 27214773)
48. ZHANG Y, CENTER DM, WU DM et al Processing and activation of pro-interleukin-16 by caspase-3. J Biol Chem 1998; 273 1144-9. (Pubitemid 28049215)
49. CRUIKSHANK WW, KORNFELD H, CENTER DM: Interleukin-16. J Leukocyte Biol 2000; 67: 757-66.
50. ZHANG Y, KORNFELD H, CRUIKSHANK WW, KIM S, REARDON CC, CENTER DM: Nuclear translocation of the N-terminal prodomain of interleukin-16. J Biol Chem 2001; 276: 1299-303. (Pubitemid 32096559)
51. FESKE S, GILTNANE J, DOLMETSCH R, STAUDT LM, RAO A: Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol 2001; 2: 316-24. (Pubitemid 33706342)
52. CRISTILLO AD, BIERER BE: Identification of novel targets of immunosuppressive agents by cDNA-based microarray analysis. J Biol Chem 2002; 277: 4465-76. (Pubitemid 34968714)